COL17A1 and pancreatic adenocarcinoma: Furthermore, we explored the correlation between COL17A1 expression and clinicopathological characteristics in pancreatic cancer and observed that the overexpression of COL17A1 in pancreatic adenocarcinoma patients is significantly correlated with overall survival (OS).